Net Loss Per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - shares |
3 Months Ended | 12 Months Ended | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||||||||||
Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||
Antidilutive securities | 67,748,300 | 45,466,135 | 24,199,613 | 23,097,930 | ||||||||||||
Convertible Preferred Stock [Member] | ||||||||||||||||
Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||
Antidilutive securities | 17,863,934 | 17,863,934 | 17,863,934 | 17,863,934 | ||||||||||||
Convertible Notes Payable [Member] | ||||||||||||||||
Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||
Antidilutive securities | 46,912,311 | 24,630,146 | [1] | 3,363,624 | 2,251,941 | [2] | ||||||||||
Convertible Loans [Member] | ||||||||||||||||
Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||
Antidilutive securities | [3] | [4] | ||||||||||||||
Options to Purchase Common Stock [Member] | ||||||||||||||||
Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Line Items] | ||||||||||||||||
Antidilutive securities | 2,972,055 | 2,972,055 | 2,972,055 | 2,982,055 | ||||||||||||
|